AAAAAA

   
Results: 1-10 |
Results: 10
Heterozygous carrier of G20210A prothrombin mutation used oral contraceptive treatment for 23 years without thrombotic events, and developed cerebralvenous thrombosis 1 month after resumption of the medication at the age of50
Authors: Tormene, D Simioni, P Sartori, MT Girolami, A
Citation: D. Tormene et al., Heterozygous carrier of G20210A prothrombin mutation used oral contraceptive treatment for 23 years without thrombotic events, and developed cerebralvenous thrombosis 1 month after resumption of the medication at the age of50, BL COAG FIB, 12(2), 2001, pp. 161-162
Role of the 4G/5G polymorphism of PAI-1 gene promoter on PAI-1 levels in obese patients - Influence of fat distribution and insulin-resistance
Authors: Sartori, MT Vettor, R De Pergola, G De Mitrio, V Saggiorato, G Della Mea, P Patrassi, GM Lombardi, AM Fabris, R Girolami, A
Citation: Mt. Sartori et al., Role of the 4G/5G polymorphism of PAI-1 gene promoter on PAI-1 levels in obese patients - Influence of fat distribution and insulin-resistance, THROMB HAEM, 86(5), 2001, pp. 1161-1169
Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study
Authors: Crowther, MA Roberts, J Roberts, R Johnston, M Stevens, P Skingley, P Patrassi, GM Sartori, MT Hirsh, J Prandoni, P Weitz, JI Gent, M Ginsberg, JS
Citation: Ma. Crowther et al., Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study, THROMB HAEM, 85(3), 2001, pp. 390-394
Are fasting plasma homocyst(e)ine levels heritable? A study of normotensive twins
Authors: Cesari, M Burlina, AB Narkiewicz, K Sartori, MT Sacchetto, A Rossi, GP
Citation: M. Cesari et al., Are fasting plasma homocyst(e)ine levels heritable? A study of normotensive twins, J INVES MED, 48(5), 2000, pp. 351-358
Combined heterozygous plasminogen deficiency and factor V Leiden defect inthe same kindred
Authors: Sartori, MT Simioni, P Patrassi, GM Theodoridis, P Tormene, D Girolami, A
Citation: Mt. Sartori et al., Combined heterozygous plasminogen deficiency and factor V Leiden defect inthe same kindred, CL APPL T-H, 6(1), 2000, pp. 36-40
Improved fibrinolytic capacity after withdrawal of steroid immunosuppression in renal transplant recipients
Authors: Sartori, MT Patrassi, GM Rigotti, P Marchini, F Fioretti, M Spiezia, L Girolami, A
Citation: Mt. Sartori et al., Improved fibrinolytic capacity after withdrawal of steroid immunosuppression in renal transplant recipients, TRANSPLANT, 69(10), 2000, pp. 2116-2121
Determinants of plasma levels of plasminogen activator inhibitor-1 - A study of normotensive twins
Authors: Cesari, M Sartori, MT Patrassi, GM Vettore, S Rossi, GP
Citation: M. Cesari et al., Determinants of plasma levels of plasminogen activator inhibitor-1 - A study of normotensive twins, ART THROM V, 19(2), 1999, pp. 316-320
Familial association of hypoplasminogenemia and heterozygous factor V deficiency
Authors: Sartori, MT Patrassi, GM Theodoridis, P Danesin, C Abati, C Girolami, A
Citation: Mt. Sartori et al., Familial association of hypoplasminogenemia and heterozygous factor V deficiency, CL APPL T-H, 5(4), 1999, pp. 277-281
A paradoxical side-effect of antiaggregating treatment with ticlopidine: the Moschowitz syndrome
Authors: Fabris, F Luzzatto, G Sartori, MT Zanella, I Girolami, A
Citation: F. Fabris et al., A paradoxical side-effect of antiaggregating treatment with ticlopidine: the Moschowitz syndrome, HAEMATOLOG, 84(8), 1999, pp. 760-762
4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis
Authors: Sartori, MT Wiman, B Vettore, S Dazzi, F Girolami, A Patrassi, GM
Citation: Mt. Sartori et al., 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis, THROMB HAEM, 80(6), 1998, pp. 956-960
Risultati: 1-10 |